Top

Published in:

01-11-2013 | Current Concept Review

Surgical management of spasticity

Author: Andrew Roberts

Published in: Journal of Children's Orthopaedics | Issue 5/2013

Abstract

Intractable and severe spasticity in childhood has the ability to impact on the quality of life, function and care of the child. Where medical and physical measures have proved insufficient, a surgical approach may be pursued. Irrespective of the underlying pathology, intrathecal baclofen will reduce spasticity in a controllable and reversible fashion, whereas selective dorsal rhizotomy is reserved for the management of bilateral cerebral palsy due to early birth. Owing to the potential for complications of intrathecal baclofen and the permanence of selective dorsal rhizotomy, careful selection and preparation are required to produce satisfactory results.

Lance JW, Burke D (1974) Mechanisms of spasticity. Arch Phys Med Rehabil 55(8):332–337

Yam WK, Leung MS (2006) Interrater reliability of Modified Ashworth Scale and Modified Tardieu Scale in children with spastic cerebral palsy. J Child Neurol 21(12):1031–1035CrossRef

Damiano DL, Quinlivan JM, Owen BF, Payne P, Nelson KC, Abel MF (2002) What does the Ashworth scale really measure and are instrumented measures more valid and precise? Dev Med Child Neurol 44(2):112–118CrossRef

Wartenberg R (1951) Pendulousness of the legs as a diagnostic test. Neurology 1(1):18–24CrossRef

Rekand T (2010) Clinical assessment and management of spasticity: a review. Acta Neurol Scand Suppl 190:62–66CrossRef

Sheean G (2002) The pathophysiology of spasticity. Eur J Neurol 9(Suppl 1):3–9; discussion 53–61CrossRef

Hägglund G, Wagner P (2008) Development of spasticity with age in a total population of children with cerebral palsy. BMC Musculoskelet Disord 9:150CrossRef

Albright AL, Barry MJ, Shafton DH, Ferson SS (2001) Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43(10):652–657CrossRef

Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF (1991) Intrathecal baclofen for intractable axial dystonia. Neurology 41(7):1141–1142CrossRef

10.

Watve SV, Sivan M, Raza WA, Jamil FF (2012) Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord 50(2):107–111CrossRef

11.

Meythaler JM, Roper JF, Brunner RC (2003) Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil 84(5):638–642CrossRef

12.

Samson-Fang L, Gooch J, Norlin C (2000) Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy. Dev Med Child Neurol 42(8):561–565CrossRef

13.

Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87(3):409–414CrossRef

14.

Albright AL, Awaad Y, Muhonen M, Boydston WR, Gilmartin R, Krach LE, Turner M, Zidek KA, Wright E, Swift D, Bloom K (2004) Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101(1 Suppl):64–68

15.

Bennett MI, Tai YM, Symonds JM (1994) Staphylococcal meningitis following synchromed intrathecal pump implant: a case report. Pain 56(2):243–244CrossRef

16.

Fjelstad AB, Hommelstad J, Sorteberg A (2009) Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 4(5):487–493CrossRef

17.

Wunderlich CA, Krach LE (2006) Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study. Dev Med Child Neurol 48(6):450–455CrossRef

18.

Burn SC, Zeller R, Drake JM (2010) Do baclofen pumps influence the development of scoliosis in children? J Neurosurg Pediatr 5(2):195–199CrossRef

19.

Ginsburg GM, Lauder AJ (2007) Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. Spine (Phila Pa 1976) 32(24):2745–2750CrossRef

20.

Sansone JM, Mann D, Noonan K, Mcleish D, Ward M, Iskandar BJ (2006) Rapid progression of scoliosis following insertion of intrathecal baclofen pump. J Pediatr Orthop 26(1):125–128CrossRef

21.

Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML (2004) Care provider assessment of intrathecal baclofen in children. Dev Med Child Neurol 46(8):548–552CrossRef

22.

Shilt JS, Lai LP, Cabrera MN, Frino J, Smith BP (2008) The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthop 28(6):684–687CrossRef

23.

Liu JK, Walker ML (2005) Posterior cervical approach for intrathecal baclofen pump insertion in children with previous spinal fusions. Technical note. J Neurosurg 102(1 Suppl):119–122

24.

Deer TR, Raso LJ, Garten TG (2007) Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication. Pain Med 8(3):259–262CrossRef

25.

McCoy AA, Fox MA, Schaubel DE, Ayyangar RN (2006) Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. Arch Phys Med Rehabil 87(11):1503–1508CrossRef

26.

Steinbok P, Daneshvar H, Evans D, Kestle JR (1995) Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy. Pediatr Neurosurg 22(5):255–264; discussion 265CrossRef

27.

Langerak NG, Tam N, Vaughan CL, Fieggen AG, Schwartz MH (2012) Gait status 17–26 years after selective dorsal rhizotomy. Gait Posture 35(2):244–249CrossRef

28.

O’Brien DF, Park TS, Puglisi JA, Collins DR, Leuthardt EC (2004) Effect of selective dorsal rhizotomy on need for orthopedic surgery for spastic quadriplegic cerebral palsy: long-term outcome analysis in relation to age. J Neurosurg 101(1 Suppl):59–63

29.

O’Brien DF, Park TS (2006) A review of orthopedic surgeries after selective dorsal rhizotomy. Neurosurg Focus 21(2):e2

30.

Langerak NG, Vaughan CL, Hoffman EB, Figaji AA, Fieggen AG, Peter JC (2009) Incidence of spinal abnormalities in patients with spastic diplegia 17 to 26 years after selective dorsal rhizotomy. Childs Nerv Syst 25(12):1593–1603CrossRef

31.

Golan JD, Hall JA, O’Gorman G, Poulin C, Benaroch TE, Cantin MA, Farmer JP (2007) Spinal deformities following selective dorsal rhizotomy. J Neurosurg 106(6 Suppl):441–449

32.

Johnson MB, Goldstein L, Thomas SS, Piatt J, Aiona M, Sussman M (2004) Spinal deformity after selective dorsal rhizotomy in ambulatory patients with cerebral palsy. J Pediatr Orthop 24(5):529–536CrossRef

33.

Roberts A, Stewart C, Cole G, Farmer S, Patrick J (2002) Energy consumption in spasticity. Dev Med Child Neurol 44(4):284CrossRef

34.

Carroll KL, Moore KR, Stevens PM (1998) Orthopedic procedures after rhizotomy. J Pediatr Orthop 18(1):69–74

35.

Hicdonmez T, Steinbok P, Beauchamp R, Sawatzky B (2005) Hip joint subluxation after selective dorsal rhizotomy for spastic cerebral palsy. J Neurosurg 103(1 Suppl):10–16

36.

Cole GF, Farmer SE, Roberts A, Stewart C, Patrick JH (2007) Selective dorsal rhizotomy for children with cerebral palsy: the Oswestry experience. Arch Dis Child 92(9):781–785CrossRef

37.

Davids JR, Holland WC, Sutherland DH (1993) Significance of the confusion test in cerebral palsy. J Pediatr Orthop 13(6):717–721CrossRef

38.

Boyd RN, Graham HK (1999) Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol 6(S4):s23–s35CrossRef

39.

Butler PB, Saavedra S, Sofranac M, Jarvis SE, Woollacott MH (2010) Refinement, reliability, and validity of the segmental assessment of trunk control. Pediatr Phys Ther 22(3):246–257CrossRef

40.

Fowler EG, Staudt LA, Greenberg MB, Oppenheim WL (2009) Selective Control Assessment of the Lower Extremity (SCALE): development, validation, and interrater reliability of a clinical tool for patients with cerebral palsy. Dev Med Child Neurol 51(8):607–614CrossRef

Title: Surgical management of spasticity
Author: Andrew Roberts
Publication date: 01-11-2013
Publisher: Springer Berlin Heidelberg
Published in: Journal of Children's Orthopaedics / Issue 5/2013
Print ISSN: 1863-2521
Electronic ISSN: 1863-2548
DOI: https://doi.org/10.1007/s11832-013-0512-9

At a glance: The STEP trials

Springer Medicine

Surgical management of spasticity

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Hip surveillance and management of the displaced hip in cerebral palsy

Upcoming meetings and courses

Biomechanics and muscle function during gait

Seating

The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study

Overview of foot deformity management in children with cerebral palsy